Introduction
Polycystic Ovarian Syndrome (PCOS) is the most common endocrine disorder in women 1 . It generates numerous health problems and it is usually common at puberty. It affects 4-12% women of reproductive age 2 . Despite being heterogeneous in nature, the hallmarks of the disease are hyperandrogenism and chronic anovulation. In a view of an increased prevalence of PCOS in Caribbean Hispanics, it has been suggested that there might be ethnic variation in overt features and biochemical abnormalities of PCOS 3 . Of the community studies conducted so far to determine the prevalence of polycystic ovaries, the highest reported prevalence was 52% 
Materials and Methods
This is a cross-sectional comparative study which was undertaken in For each and every subject a separate data collection sheet was prepared. Subjects were selected by a purposive sampling procedure according to the availability of the patients who fulfilled the inclusion criteria. Sample size calculation and blood collection were taken under the following procedure. Since the ultimate test of association between IR and TSH or BMI in this study was multiple regression analysis, the sample size was calculated based on the number of independent variables. The simplified method, as described by Mascie Taylor and Rahman was used. In this case n were >104+m, where m is the number of independent variables for testing the multiple correlations. With IR as dependent variable and TSH, BMI and age as independent variables, we have a small sample size ≥104+1, ≥105, For better power of the study we included 150 PCOS subjects. Whole venous blood was taken from the subject following an overnight fasting (12hr) in the follicular phase of a spontaneous or progestin induced cycle in women who were not on any form of medication. Blood sample from each subject was taken by a 5 cc disposable syringe. After 30 minutes of blood drawing, serum was separated by centrifugation at 3000 rpm for 10 min and then the serum was collected at least 600 µl in each tube (4) . Blood samples were maintained at 4°c until separation and plasma was frozen at -20°c within an hour of sample collection. Fasting plasma glucose, insulin & TSH were assayed by appropriate procedure. Serum was not allowed to be thawed until the assay is performed.
═►Glycemic status of the study subjects was measured by OGTT, using Glucose Oxidase method (Randox, UK).
═►TSH was measured by Chemiluminescent
Immunometric Assay (Immulite, USA). ═►Serum C-peptide was measured by ELISA method (Linco Research Ltd, USA).
═►IR was calculated by fasting glucose and C-peptide using HOMA using HOMA Software Calculator-2.
• Operational definitions ═►Serum TSH (µlU/ml) level were divided into lower normal and higher (subclinical hypothyroidism) with median (2.49) value as the cut-off point.
═►Insulin sensitivity (HOMA %S) was divided into insulin resistant and insulin nonresistant groups with 50% HOMA%S as the cut-off point.
Statistical analysis
Data were compiled in pre-designed case record forms and expressed as M±SD or Median (range) as applicable. In case of continuous variable, difference between groups was explored by using Student's t-test (normally distributed data) or Mann-Whitney Test (for nonparametric distribution). Simple correlation between two groups was analyzed by Pearson's correlation test. Association between IR and TSH was further investigated by multivariate analysis with IR as dependent variables and TSH and other relevant clinical, anthropometric or biochemical factors as independent variables. In all cases p<0.05 was considered as significant. SPSS software for windows version 12.0 was used to analysis the data.
Results
In the present study, 151 PCOS women were included. All the subjects were within the reproductive age (15-40 years) group.
Insulin sensitivity (HOMA %S) was assessed by HOMA. The mean (±SD) serum C-peptide (nmol/l) and HOMA %S were 0.67 (±0.35) and 85 (±42) respectively. The median (Range) serum thyroid stimulating hormone (TSH) level (µlU/ml) of the study subjects was found to be 2.49 (0.66 to 20.86) ( Table-I ). Forty seven (47%) percent subjects were in the range of 50 to 100 of insulin sensitivity whereas, 26.5% were lower insulin sensitivity. In addition 16.6% and 9.9% were in the range of 101 to 150 and >150 respectively (Figure-1 ).
Fig-1:
Frequency distribution of insulin sensitivity among PCOS subjects.
About fifteen (15%) percent subjects showed TSH value >4.50 µlU/ml whereas 85% PCOS subjects showed TSH values within 0.40 to 4.50 µlU/ml range ( Figure- The median (Range) TSH level (µlU/ml) of the IR and non-resistance groups were 2.25 (0.89-5.71) and 2.58 (0.74-20.86) respectively (Table-II) . Results were expressed as Median (range), n-number of subjects
There was no correlation between insulin sensitivity and TSH among the study subjects (r=0.081, p=0.323) (Fig-3) .
Fig-3:
Correlation between insulin sensitivity and TSH in PCOS subjects.
Discussion
PCOS is now considered as a disorder of the MS, which increases the risk of Type-2 diabetes mellitus and cardiovascular diseases substantially 17 . Like many other disorders of MS, IR is thought to be a central phenomenon where many of the other abnormalities converge. The increased prevalence of IR in PCOS is widely acknowledged 18 , but the exact degree of IR has been reported to vary from population to population. In a study by Deugarte et al (2005) found that the value of HOMA%S was 64.4% in USA PCOS population. In another study on Canadian population 19 , the value was 75%.
The PCOS subjects in the present study were fairly young (24±5 years, M±SD). The mean (±SD) of HOMA%S in the present population was 85 (±42) which indicate that IR in Bangladeshi PCOS subjects may be substantially less than that of USA or Canadian population. Taken as a whole only 26% of PCOS subjects were found to have HOMA %S below 50 which means that only one-fourth of the PCOS subjects in our population have severe IR.
The etiopathogenesis of IR in PCOS subjects is a matter of further controversy since multiple primary and secondary factors seem to be involved in this case. Apart from the yet undetected possible primary factors, hyperadrogenemia 11 seems to be a major contributing factor in the genesis of IR in PCOS. However, factors like age, BMI and often-antagonistic hormones also seem to play a major contributing or confounding role in this case.
Thyroid hormones are one of the most important insulin antagonists and those have been already investigated in PCOS. The frequency distribution of TSH levels (Fig-2) showed a clear pattern of thyroid function status in the PCOS subjects. Whereas 85% of subjects showed normal TSH values (0.4 -4.5 µlU/ml), 15% showed levels compatible with subclinical hypothyroidism (>4.5 µlU/ml). Janssen et al (2004) reported similar proportion of subclinical hypothyroidism in PCOS among European subjects. In a cross sectional study of South India where the proportion of subclinical hypothyroidism 20 was found to be 20% .
HOMA-IR is an reliable yet inexpensive and empirical mathematical formula based on fasting glucose and fasting insulin levels that was developed as a surrogate measurement of clinical diabetes research to measure insulin sensitivity 21, 22 .
In the present study, insulin sensitively measured by this method showed no significant difference of TSH level between insulin resistant and non-resistant groups. There are reports that hypothyroidism, even in the subclinical stage, is associated with IR 23,24 .
However, Ganie et al (2011) reported that subclinical hypothyroidism is not associated with alteration in phenotypic expression and IR in young women with PCOS. This is in contrast to the findings of Gang et al (2010) who found significant negative correlation between TSH and HOMA-IR in PCOS subjects. In this study, there was lack of association between insulin sensitivity and TSH reflected in the lack of significant correlation between HOMA%S and TSH in PCOS. The present data is not consistent with 
Conclusion
Only about one-fourth subjects with PCOS have severe IR. About 15% of PCOS subjects suffer from subclinical hypothyroidism. Thyroid function abnormality seems to have no association with IR in PCOS.
